TrialHelicobacter

Efficacy and Safety of Vonoprazan-Based Dual Therapies With Different Antibiotics Versus Bismuth-Containing Quadruple Therapy for Helicobacter pylori Eradication: A Prospective, Four-Arm, Randomized Controlled Trial.

Jie Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.